<DOC>
	<DOC>NCT00760448</DOC>
	<brief_summary>This trial is conducted in UK. The aim of this clinical trial is to investigate lowering the blood sugar and symptoms experienced during hypoglycaemia</brief_summary>
	<brief_title>Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin, beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Isophane Insulin, Human</mesh_term>
	<mesh_term>Insulin, Isophane</mesh_term>
	<criteria>Signed and dated informed consent obtained before any trialrelated activities. Type 1 diabetes Treatment with insulin for minimum three months Duration of diabetes for more than 12 months Body Mass Index (BMI) less than 30 kg/m2 HbA1c equal to or greater than 10 % based on analysis from central laboratory Participation in any other clinical trial involving other investigational products within the last three months Current treatment with insulin in a daily dose above 100 U Episode of symptomatic hypoglycaemia, or a capillary plasma glucose value of less than 3.5 mmol/L in the past two weeks Hypoglycaemic unawareness or severe autonomic neuropathy Current treatment with drugs known to interfere with glucose metabolism such as systemic corticosteroids, nonselective betablockers and MAO inhibitors Current treatment with oral antidiabetic drugs Impaired hepatic function measured as ALAT of more than two times the upper reference limit Impaired renal function measured as creatinine of more than 150 micromol/L (1.7 mg/dL) Cardiac problems defined as decompensated heart failure (NYHA class III and IV) at any time and/or angina pectoris and/or myocardial infarction within the last 12 months Known or suspected allergy to trial product or related products Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation Blood donation of more than 500 mL within the last three months Any condition that the Investigator and/or the Sponsor feels would interfere with study participation or evaluation of results Pregnancy or intention of becoming pregnant, breastfeeding or judged to be using inadequate contraceptive methods. Adequate contraceptive methods are sterilisation, intrauterine device (IUD), oral contraceptives or consistent use of barrier methods Previous participation in this trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>